Online ISSN: 2331-4737
About Oncoscience
Our mission is to cover the rapidly growing field of cancer research. We aim to focus on emergent topics not currently covered by other journals.
Oncoscience has also a special mission: freeing researchers in oncology from publication costs. It is free for both readers and authors.

Pazopanib in EWSR1-NFATC2 Translocation-associated Bone Sarcoma

News

January 12, 2024
PRESS RELEASE: On September 20, 2023, a new case report was published in Oncoscience, entitled, “Activity of pazopanib in EWSR1-NFATC2 translocation-associated bone sarcoma.” continue reading »

Lipiodol: From Intrusion Until Exile From the Tumor Microenvironment

News

January 5, 2024
PRESS RELEASE: On August 17, 2023, a new editorial was published in Oncoscience, entitled, “Lipiodol: from intrusion until exile from the tumor microenvironment.” continue reading »

DDX53: A Potential Early Esophageal Cancer Antigen

News

November 17, 2023
PRESS RELEASE: On November 10, 2023, a new research paper was published in Oncoscience, entitled, “An immunoinformatics assessment of the cancer testis antigen, DDX53, as a potential early esophageal cancer antigen.” continue reading »

Management of Recurrent Gastrointestinal Cancer with Ripretinib and Surgery

News

November 3, 2023
PRESS RELEASE: On September 20, 2023, a new case report was published in Oncoscience, entitled, “Multi-disciplinary management of recurrent gastrointestinal stromal tumor harboring KIT exon 11 mutation with the switch-control kinase inhibitor ripretinib and surgery.” continue reading »